675 related articles for article (PubMed ID: 24055479)
1. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
[TBL] [Abstract][Full Text] [Related]
2. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
4. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
[TBL] [Abstract][Full Text] [Related]
5. Prediction of thrombolytic therapy after stroke-bypass transportation: the Maria Prehospital Stroke Scale score.
Hasegawa Y; Sasaki N; Yamada K; Ono H; Kumai J; Tsumura K; Suzuki K; Nozaki H; Nakayama H; Takumi I; Nikaido H; Katabami T; Ueda T; Suzuki S; Iwai R; Takahashi H; Shigeno T
J Stroke Cerebrovasc Dis; 2013 May; 22(4):514-9. PubMed ID: 23489953
[TBL] [Abstract][Full Text] [Related]
6. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
[TBL] [Abstract][Full Text] [Related]
9. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
[TBL] [Abstract][Full Text] [Related]
10. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
11. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
12. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
[TBL] [Abstract][Full Text] [Related]
14. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
15. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
16. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
Rusanen H; Saarinen JT; Sillanpää N
Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke.
Jeong HS; Kwon HJ; Kang CW; Song HJ; Koh HS; Park SM; Lim JG; Shin JE; Lee SH; Kim J
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e283-9. PubMed ID: 24529352
[TBL] [Abstract][Full Text] [Related]
18. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of the Kurashiki prehospital stroke scale in identifying thrombolytic candidates in acute ischemic stroke.
Jang J; Chung SP; Park I; You JS; Lee HS; Park JW; Chung TN; Chung HS; Lee HS
Yonsei Med J; 2014 Mar; 55(2):410-6. PubMed ID: 24532511
[TBL] [Abstract][Full Text] [Related]
20. Stroke scale items associated with neurologic deterioration within 24 hours after recombinant tissue plasminogen activator therapy.
Nanri Y; Yakushiji Y; Hara M; Eriguchi M; Okada R; Yukitake M; Hara H
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1117-24. PubMed ID: 23199533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
